PeRsOnaliSed care Planning for oldER people with frailty (PROSPER): protocol for a randomised controlled trial

Background Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Current controlled trials in cardiovascular medicine Ročník 25; číslo 1; s. 8 - 13
Hlavní autoři:	Heaven, Anne, Bower, Peter, Day, Florence, Farrin, Amanda, Fernadez, Catherine, Foster, Marilyn, Foy, Robbie, Hawkins, Rebecca, Hulme, Claire, Humphrey, Sara, Lawton, Rebecca, Parker, Catriona, Thompson, Ellen, West, Robert, Clegg, Andrew
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 02.01.2024 BioMed Central Ltd Springer Nature B.V BMC
Témata:	Activities of Daily Living Age Aged Biomedicine Care and treatment Cost analysis Cost-Benefit Analysis Disease management eFI Electronic health records England Feasibility studies Frail elderly Frailty Frailty - diagnosis Frailty - therapy Goal setting Health Sciences Health services Humans Medicine Medicine & Public Health Mental health Multicenter Studies as Topic Older people Palliative treatment Patients Personalised-Care-Planning Planning Primary care Quality of Life Questionnaires Randomized Controlled Trials as Topic RCT Registration Statistics for Life Sciences Study Protocol Surveys and Questionnaires Teams England United Kingdom United Kingdom > UK Frailty eFI Personalised-Care-Planning RCT Older people Quality of life
ISSN:	1745-6215, 1745-6215
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Background Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty. Methods Following an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial. Discussion The PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation. Trial registration mailto:ISRCTN16123291. Registered on 28 August 2020.
AbstractList	Background Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty. Methods Following an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial. Discussion The PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation. Trial registration mailto:ISRCTN16123291. Registered on 28 August 2020. Keywords: Personalised-Care-Planning, Quality of life, Older people, Frailty, eFI, RCT Background Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty. Methods Following an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial. Discussion The PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation. Trial registration mailto:ISRCTN16123291. Registered on 28 August 2020. Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty. Following an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial. The PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation. ISRCTN16123291 . Registered on 28 August 2020. BackgroundFrailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty.MethodsFollowing an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial.DiscussionThe PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation.Trial registrationmailto:ISRCTN16123291. Registered on 28 August 2020. Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty.BACKGROUNDFrailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty.Following an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial.METHODSFollowing an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial.The PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation.DISCUSSIONThe PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation.ISRCTN16123291 . Registered on 28 August 2020.TRIAL REGISTRATIONISRCTN16123291 . Registered on 28 August 2020. Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty. Following an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial. The PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation. Abstract Background Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean older people can be vulnerable to sudden, dramatic changes in health because of relatively small problems. Older people with frailty are at increased risk of adverse outcomes including disability, hospitalisation, and care home admission, with associated reduction in quality of life and increased NHS and social care costs. Personalised Care Planning offers an anticipatory, preventative approach to supporting older adults to live independently for longer, but it has not been robustly evaluated in a population of older adults with frailty. Methods Following an initial feasibility study, this multi-centre, individually randomised controlled trial aims to establish whether personalised care planning for older people improves health-related quality of life. It will recruit 1337 participants from general practices across Yorkshire and Humber and Mid-Mersey in the North of England. Eligible patients will be aged 65 and over with an electronic frailty index score of 0.21 or above, living in their own homes, without severe cognitive impairment and not in receipt of end-of-life care. Following confirmation of eligibility, informed consent and baseline data collection, participants will be individually randomised to the PeRsOnaliSed care Planning for oldER people with frailty (PROSPER) intervention or usual care in a 2.6:1 allocation ratio. Participants will not be blinded to allocation, but data collection and analysis will be blinded. The intervention will be delivered over 12 weeks by a Personal Independence Co-ordinator worker based within a voluntary sector organisation, Age UK. The primary outcomes are health-related quality of life, measured using both the physical and mental components of the Short-Form 12 Item Health Questionnaire at 12 months after randomisation. Secondary outcomes comprise activities of daily living, self-management capabilities and loneliness, admission to care homes, hospitalisations, and health and social care resource use at 12 months post randomisation. Parallel cost-effectiveness and process evaluations will be conducted alongside the trial. Discussion The PROSPER study will evaluate the effectiveness and cost-effectiveness of a personalised care planning approach for older people with frailty and inform the process of its implementation. Trial registration ISRCTN16123291 . Registered on 28 August 2020.
ArticleNumber	8
Audience	Academic
Author	Bower, Peter Fernadez, Catherine Lawton, Rebecca West, Robert Hawkins, Rebecca Parker, Catriona Foy, Robbie Day, Florence Farrin, Amanda Foster, Marilyn Clegg, Andrew Humphrey, Sara Hulme, Claire Thompson, Ellen Heaven, Anne
Author_xml	– sequence: 1 givenname: Anne orcidid: 0000-0003-2959-2241 surname: Heaven fullname: Heaven, Anne email: anne.heaven@bthft.nhs.uk organization: Academic Unit for Ageing and Stroke Research, University of Leeds, Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Leeds Institute of Health Sciences, School of Medicine, University of Leeds – sequence: 2 givenname: Peter surname: Bower fullname: Bower, Peter organization: NIHR Older People and Frailty Policy Research Unit, Centre for Primary Care and Health Services Research, Manchester Academic Health Science Centre, University of Manchester – sequence: 3 givenname: Florence surname: Day fullname: Day, Florence organization: Leeds Institute of Clinical Trials Research (LICTR), Clinical Trials Research Unit, University of Leeds – sequence: 4 givenname: Amanda surname: Farrin fullname: Farrin, Amanda organization: Leeds Institute of Clinical Trials Research (LICTR), Clinical Trials Research Unit, University of Leeds – sequence: 5 givenname: Catherine surname: Fernadez fullname: Fernadez, Catherine organization: Leeds Institute of Clinical Trials Research (LICTR), Clinical Trials Research Unit, University of Leeds – sequence: 6 givenname: Marilyn surname: Foster fullname: Foster, Marilyn organization: PPI Representative, c/o Academic Unit for Ageing and Stroke Research, University of Leeds, Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Duckworth Lane – sequence: 7 givenname: Robbie surname: Foy fullname: Foy, Robbie organization: Leeds Institute of Health Sciences, School of Medicine, University of Leeds – sequence: 8 givenname: Rebecca surname: Hawkins fullname: Hawkins, Rebecca organization: Academic Unit for Ageing and Stroke Research, University of Leeds, Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Leeds Institute of Health Sciences, School of Medicine, University of Leeds – sequence: 9 givenname: Claire surname: Hulme fullname: Hulme, Claire organization: Health Economics Group, Institute of Health Research, University of Exeter – sequence: 10 givenname: Sara surname: Humphrey fullname: Humphrey, Sara organization: OPMH & Dementia at Yorkshire and Humber Clinical Network – sequence: 11 givenname: Rebecca surname: Lawton fullname: Lawton, Rebecca organization: School of Psychology, University of Leeds – sequence: 12 givenname: Catriona surname: Parker fullname: Parker, Catriona organization: Cancer Clinical Trial Centre, Weston Park Cancer Centre – sequence: 13 givenname: Ellen surname: Thompson fullname: Thompson, Ellen organization: Leeds Institute of Clinical Trials Research (LICTR), Clinical Trials Research Unit, University of Leeds – sequence: 14 givenname: Robert surname: West fullname: West, Robert organization: Leeds Institute of Health Sciences, School of Medicine, University of Leeds – sequence: 15 givenname: Andrew surname: Clegg fullname: Clegg, Andrew organization: Academic Unit for Ageing and Stroke Research, University of Leeds, Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Leeds Institute of Health Sciences, School of Medicine, University of Leeds
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38167481$$D View this record in MEDLINE/PubMed
BookMark	eNp9kl1v0zAYhSM0xD7gD3CBInEzLjL8EScxN9M0FZg0qVUH19Yb53XnybWLnYL273Hbsa0IkSiK5TznROf1OS4OfPBYFG8pOaO0az4myknDK8Ly03aireiL4oi2tagaRsXBs_VhcZzSHSE1l7x-VRzyjjZt3dGjws9wnqYenL3BodQQsZw58N76RWlCLIMbJvNyhWHlsPxlx9vSRLBuvC9PZ_PpzWwy__CpXMUwBh3cVgFlBD-EpU0bw-DHGJzLyzFacK-LlwZcwjcP75Pi--fJt8uv1fX0y9XlxXWlhZBj1aMciJGM1pR0jewpG4xEpABSm77pzdAL5LXBXrRt1xIwXScaRNah4WAGflJc7XyHAHdqFe0S4r0KYNV2I8SFgjha7VA1ADUg5SgQ83y0NAxYxxpjCNOd4dnrfOe1WvdLHDTmSOD2TPe_eHurFuGnoqQVkrc0O5w-OMTwY41pVHk6Gl0eNIZ1UkxSQiVjQmT0_V_oXVjHfD4bikiSr1o-UQvICaw3If9Yb0zVRR4IkbJuWKbO_kHle8ClzSeDxub9PcG750kfI_6pSwbYDtAxpBTRPCKUqE0n1a6TKndSbTupNiK-E6UM-wXGp0j_Uf0GByjjRQ
Cites_doi	10.1001/jama.2022.21022 10.1371/journal.pmed.1000111 10.3399/bjgp14X681385 10.1080/08870449808407422 10.1007/978-3-319-15744-3 10.3399/bjgp10X514819 10.1093/oso/9780198526629.001.0001 10.1191/1740774505cn076oa 10.1016/S0167-6296(01)00130-8 10.1111/hsc.13450 10.1093/ageing/30.4.337 10.1002/14651858.CD010523.pub2 10.1136/bmj.e3526 10.1136/bmj.g1687 10.1186/s40814-020-00598-x 10.1037/0033-295X.84.2.191 10.1016/S0140-6736(12)62167-9 10.1111/j.1532-5415.2006.00738.x 10.1093/ageing/afw039 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0 10.3399/bjgp20X714017
ContentType	Journal Article
Copyright	The Author(s) 2023 2023. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA
DOI	10.1186/s13063-023-07857-1
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central Database Suite (ProQuest) ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ: Directory of Open Access Journal (DOAJ)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE Publicly Available Content Database MEDLINE - Academic
Database_xml	– sequence: 1 dbid: DOA name: DOAJ: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7RV name: Nursing & Allied Health Database (Proquest) url: https://search.proquest.com/nahs sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1745-6215
EndPage	13
ExternalDocumentID	oai_doaj_org_article_6aa4ae13e5ee439c9f2a2826ff02c8f3 PMC10759371 A778099462 38167481 10_1186_s13063_023_07857_1
Genre	Clinical Trial Protocol Journal Article
GeographicLocations	England United Kingdom United Kingdom--UK
GeographicLocations_xml	– name: England – name: United Kingdom – name: United Kingdom--UK
GrantInformation_xml	– fundername: Programme Grants for Applied Research grantid: RP-PG-0216-20003 funderid: http://dx.doi.org/10.13039/501100007602 – fundername: Programme Grants for Applied Research grantid: RP-PG-0216-20003
GroupedDBID	--- 0R~ 123 2-G 29Q 2WC 53G 5VS 6PF 7RV 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACUHS ADBBV ADRAZ ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHYZX AIAGR ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NAPCQ O5R O5S OVT PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP WOQ WOW ~8M AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 5GY 7XB 8FK AHMBA AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI XSB 7X8 5PM
ID	FETCH-LOGICAL-c559t-be9d0f921410869b12df9ee1aa9cfb6bfdb5e34feb577870af8856ee28ef3afd3
IEDL.DBID	DOA
ISICitedReferencesCount	2
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001135358100019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1745-6215
IngestDate	Tue Oct 14 19:05:00 EDT 2025 Tue Nov 04 02:06:09 EST 2025 Sun Nov 09 09:37:15 EST 2025 Sun Oct 19 01:28:00 EDT 2025 Sat Nov 29 14:21:00 EST 2025 Tue Nov 04 18:31:34 EST 2025 Thu Apr 03 07:08:00 EDT 2025 Sat Nov 29 06:10:22 EST 2025 Sat Sep 06 07:31:52 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Frailty eFI Personalised-Care-Planning RCT Older people Quality of life
Language	English
License	2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c559t-be9d0f921410869b12df9ee1aa9cfb6bfdb5e34feb577870af8856ee28ef3afd3
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 content type line 23
ORCID	0000-0003-2959-2241
OpenAccessLink	https://doaj.org/article/6aa4ae13e5ee439c9f2a2826ff02c8f3
PMID	38167481
PQID	2909000049
PQPubID	44365
PageCount	13
ParticipantIDs	doaj_primary_oai_doaj_org_article_6aa4ae13e5ee439c9f2a2826ff02c8f3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10759371 proquest_miscellaneous_2910192255 proquest_journals_2909000049 gale_infotracmisc_A778099462 gale_infotracacademiconefile_A778099462 pubmed_primary_38167481 crossref_primary_10_1186_s13063_023_07857_1 springer_journals_10_1186_s13063_023_07857_1
PublicationCentury	2000
PublicationDate	2024-01-02
PublicationDateYYYYMMDD	2024-01-02
PublicationDate_xml	– month: 01 year: 2024 text: 2024-01-02 day: 02
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Current controlled trials in cardiovascular medicine
PublicationTitleAbbrev	Trials
PublicationTitleAlternate	Trials
PublicationYear	2024
Publisher	BioMed Central BioMed Central Ltd Springer Nature B.V BMC
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC
References	A Bandura (7857_CR5) 1977; 84 7857_CR17 7857_CR18 7857_CR19 RMC Edlin (7857_CR27) 2015 7857_CR3 S Nikolova (7857_CR13) 2022; 30 A Bandura (7857_CR6) 1998; 13 DHM Reeves (7857_CR8) 2012; 64 Department of Health (7857_CR16) 2005 7857_CR9 A Clegg (7857_CR4) 2013; 381 L Dawson (7857_CR20) 2009; 6 7857_CR12 K Rockwood (7857_CR1) 2006; 54 NJ Butcher (7857_CR15) 2022; 328 7857_CR10 A Heaven (7857_CR11) 2020; 6 N Kime (7857_CR28) 2020; 74 PRD Bower (7857_CR7) 2013 J Brazier (7857_CR24) 2002; 21 D Mangin (7857_CR2) 2012; 344 C Roberts (7857_CR23) 2005; 2 SJ Walters (7857_CR21) 2001; 30 7857_CR25 A Clegg (7857_CR14) 2016; 45 F Angst (7857_CR22) 2001; 45 ACK Briggs (7857_CR26) 2006
References_xml	– volume: 328 start-page: 2252 issue: 22 year: 2022 ident: 7857_CR15 publication-title: Jama. doi: 10.1001/jama.2022.21022 – volume: 6 start-page: e1000111 issue: 9 year: 2009 ident: 7857_CR20 publication-title: PLoS Med. doi: 10.1371/journal.pmed.1000111 – volume: 64 start-page: 568 issue: 626 year: 2012 ident: 7857_CR8 publication-title: Br J Gen Pract : J Royal Coll Gen Pract. doi: 10.3399/bjgp14X681385 – volume: 74 start-page: A37-A issue: Suppl 1 year: 2020 ident: 7857_CR28 publication-title: J Epidemiol Community Health. – ident: 7857_CR10 – ident: 7857_CR12 – volume: 13 start-page: 623 issue: 4 year: 1998 ident: 7857_CR6 publication-title: Psychol Health. doi: 10.1080/08870449808407422 – volume-title: Cost-effectiveness modelling for health technology assessment year: 2015 ident: 7857_CR27 doi: 10.1007/978-3-319-15744-3 – ident: 7857_CR19 doi: 10.3399/bjgp10X514819 – volume-title: Decision modelling for health economic evaluation year: 2006 ident: 7857_CR26 doi: 10.1093/oso/9780198526629.001.0001 – ident: 7857_CR9 – volume: 2 start-page: 152 issue: 2 year: 2005 ident: 7857_CR23 publication-title: Clin Trials (London, England). doi: 10.1191/1740774505cn076oa – volume: 21 start-page: 271 issue: 2 year: 2002 ident: 7857_CR24 publication-title: J Health Econ. doi: 10.1016/S0167-6296(01)00130-8 – volume: 30 start-page: e804 issue: 3 year: 2022 ident: 7857_CR13 publication-title: Health Soc Care Community. doi: 10.1111/hsc.13450 – volume: 30 start-page: 337 issue: 4 year: 2001 ident: 7857_CR21 publication-title: Age Ageing. doi: 10.1093/ageing/30.4.337 – volume-title: Mental Capacity Act year: 2005 ident: 7857_CR16 – ident: 7857_CR3 doi: 10.1002/14651858.CD010523.pub2 – volume: 344 start-page: e3526 year: 2012 ident: 7857_CR2 publication-title: BMJ. doi: 10.1136/bmj.e3526 – volume-title: Care planning in the treatment of long-term conditions: final report of the CAPITOL project year: 2013 ident: 7857_CR7 – ident: 7857_CR18 doi: 10.1136/bmj.g1687 – volume: 6 start-page: 56 year: 2020 ident: 7857_CR11 publication-title: Pilot Feasibility Stud. doi: 10.1186/s40814-020-00598-x – volume: 84 start-page: 191 issue: 2 year: 1977 ident: 7857_CR5 publication-title: Psychol Rev. doi: 10.1037/0033-295X.84.2.191 – volume: 381 start-page: 752 issue: 9868 year: 2013 ident: 7857_CR4 publication-title: Lancet. doi: 10.1016/S0140-6736(12)62167-9 – ident: 7857_CR25 – volume: 54 start-page: 975 issue: 6 year: 2006 ident: 7857_CR1 publication-title: J Am Geriatr Soc. doi: 10.1111/j.1532-5415.2006.00738.x – volume: 45 start-page: 353 issue: 3 year: 2016 ident: 7857_CR14 publication-title: Age Ageing. doi: 10.1093/ageing/afw039 – volume: 45 start-page: 384 issue: 4 year: 2001 ident: 7857_CR22 publication-title: Arthritis Rheumatism. doi: 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0 – ident: 7857_CR17 doi: 10.3399/bjgp20X714017
SSID	ssj0043934 ssj0017864
Score	2.3609402
Snippet	Background Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with... Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with frailty mean... Background Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with... BackgroundFrailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated with... Abstract Background Frailty is common in older age and is characterised by loss of biological reserves across multiple organ systems. These changes associated...
SourceID	doaj pubmedcentral proquest gale pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Publisher
StartPage	8
SubjectTerms	Activities of Daily Living Age Aged Biomedicine Care and treatment Cost analysis Cost-Benefit Analysis Disease management eFI Electronic health records England Feasibility studies Frail elderly Frailty Frailty - diagnosis Frailty - therapy Goal setting Health Sciences Health services Humans Medicine Medicine & Public Health Mental health Multicenter Studies as Topic Older people Palliative treatment Patients Personalised-Care-Planning Planning Primary care Quality of Life Questionnaires Randomized Controlled Trials as Topic RCT Registration Statistics for Life Sciences Study Protocol Surveys and Questionnaires Teams
SummonAdditionalLinks	– databaseName: Nursing & Allied Health Database dbid: 7RV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagIMSF9yNQkJGQANGoieMkNhdU0FYcoF2lUPVm2bENK62Sstki8e-ZcZItKYILh5VWa3uVyXyeh2c8Q8hzzozMjc7jhPMSHBTnY2O0i1OfacBMKpJwv-L4Y3lwIE5O5Hw4cOuGtMpRJgZBbdsaz8h3mUxkb9C-Pf0eY9cojK4OLTQukysp6m7Ac1kdb6IIpSj4eFFGFLsdyOsQtYRPiSWQ0okyCjX7_5TMv6mmi2mTF2KnQSXt3_xfYm6RG4MxSvd69Nwml1xzh1z7NITb75Jm7qruEE31I2cpJonRsckRBWOXtks7q2ifhE7xRJf6lV4s1z_py3l1eDSfVa_eUKwE0QLcwgpNQTfaFsCFf9inyS_ha2geco982Z99fv8hHho0xDU4IuvYOGkTLxnmiopCmpRZL51LtZa1N4Xx1uQu496ZvETBoL0QeeEcEw6g4G12n2w1beMeEqphrc1BWHCdc1tLUSfWaOaLMsOS-T4ir0dOqdO-DocK_osoVM9XBXxVga8qjcg7ZOZmJtbQDj-0q69q2JKq0Jprl2Yudw7Mslp6psEBLbxPWC18FpEXCAWFOx34XevhwgI8MNbMUntAE9jXvGAR2Z7MhJdYT4dHFKhBQnTqHAIRebYZxpWY9da49gznpGiBg9cXkQc99jYkYcC35AJIFRNUTmiejjSLb6F-OHj8OZZBjMjOCODz5_r7S330bzIek-sMDL5wPMW2ydZ6deaekKv1j_WiWz0NG_MXBNFAVQ priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA9yivji90f1lAiCihbb9Cvx7ZQ9fNC7ZVePewtJM9GFpZXtnuB_70zarvbUB31YWDbJ0pn85qszmTD2JBdWFdYUcZLnFQYo4GNrDcSpzwxiJpVJOF9x8r46OpKnp2o-HArrxmr3MSUZNHUQa1m-6lDbhpwjfipqYIQxz0U0d5LEcbE8GfUvWtgsH4_H_HHdxASFTv2_6-NfDNL5YslzGdNgiA6v_R8J19nVwfHkBz1SbrAL0Nxklz8MqfVbrJnDojsmt3wJjlNBGB8vNOLo2PJ27WYL3hecc3p7y_3GrNbb7_zZfHG8nM8Wz19z6vrQIrTCCsPRDroWgUR_2JfEr_FruCjkNvt0OPv49l08XMYQ1xh0bGMLyiVeCaoLlaWyqXBeAaTGqNrb0npnC8hyD7aoSAkYL2VRAggJuO3eZXfYXtM2cI9xg2tdgYohN0XuaiXrxFkjfFll1B7fR-zFuD_6a99zQ4dYRZa6Z6FGFurAQp1G7A1t4W4m9csOP7Sbz3oQP10akxtIMygAECC18sJgsFl6n4ha-ixiTwkAmqQad7k2w-EEfGDqj6UPkCb0pfNSRGx_MhOZWE-HRwjpQRt0WqhE9cFYxB7vhmklVbg10J7RnJS8bYzwIna3R9yOJEruVrlEUuUEixOapyPN6kvoFY7RfUEtDyP2coTkz-f6O1Pv_9v0B-yKQGcvvJoS-2xvuzmDh-xS_W276jaPgnj-ADqKNm4 priority: 102 providerName: Springer Nature
Title	PeRsOnaliSed care Planning for oldER people with frailty (PROSPER): protocol for a randomised controlled trial
URI	https://link.springer.com/article/10.1186/s13063-023-07857-1 https://www.ncbi.nlm.nih.gov/pubmed/38167481 https://www.proquest.com/docview/2909000049 https://www.proquest.com/docview/2910192255 https://pubmed.ncbi.nlm.nih.gov/PMC10759371 https://doaj.org/article/6aa4ae13e5ee439c9f2a2826ff02c8f3
Volume	25
WOSCitedRecordID	wos001135358100019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: RBZ dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ: Directory of Open Access Journals customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: 7X7 dateStart: 20000401 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database (Proquest) customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: 7RV dateStart: 20000401 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: BENPR dateStart: 20000401 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database (Proquest) customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: PIMPY dateStart: 20000401 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1745-6215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043934 issn: 1745-6215 databaseCode: RSV dateStart: 20000401 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgILQXxOcIjMpISIAgWuJ82bxtqBNIrItSqMqTZce2qFSlU9sh8d9z5yRlGUK88JAoqe3Kvg_fXXz-mZCXKdMi0yoLozQtIECxLtRa2TB2iQKZiXnk91fMPheTCZ_PRXnlqC_MCWvhgVvCHeVKpcrGic2sBeNZC8cUhAm5cxGrufM4n-D19MFUOwdDxSTtt8jw_GgDM7Vfr4SrQPCjeGCGPFr_n3PyFaN0PWHy2qqpN0an98jdzoukx23v75MbtnlA7px16-QPSVPaanOOPvbUGorZXbQ_nYiCl0pXSzOuaJs9TvFTLHVrtVhuf9LXZXU-LcfVm_cUIRxWICe-haJg1MwKpAL_sM1vX8KjP_XjEfl6Ov7y4WPYnawQ1hBBbENthYmcYJjkyXOhY2acsDZWStRO59oZndkkdVZnBWq0cpxnubWMW-ChM8ljstesGvuEUAVtTQZanqosNbXgdWS0Yi4vEsS6dwF52xNaXrQAGtIHHjyXLVsksEV6tsg4ICfIi11NBL_2P4BIyE4k5L9EIiCvkJMSVRTYVatupwF0GMGu5DGMCRzjNGcBORzUBCLWw-JeFmSn2hvJRCTayCogL3bF2BLT1Rq7usQ6MbrOEK4F5KAVnd2QcKW2SDkMlQ-EajDmYUmz-O6BvyFUzxC_MCDvevn73a-_E_Xp_yDqM7LPwJ_zX5_YIdnbri_tc3K7_rFdbNYjcrOoZnifF_7OR-TWyXhSViOvl_BWfjorv8FbNZ39AtJpOk0
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwED-NgYAXvj8CA4wEAgTREufLQUJoQKdN67qqG6hvxklsqFQlo-1A-6f4G7lzko4MwdseeIhUxXbkc3_3ZZ_vAJ6EPEujTEWuF4YJOijauFmmtOubQCFmfOHZ-xWf-slgIMbjdLgCP9u7MBRW2cpEK6iLKqc98nWeemlt0L49_OZS1Sg6XW1LaNSw2NHHP9Blm7_Z_oD_71PON3sH77fcpqqAm6P1vHAznRaeSTkFOIo4zXxemFRrX6k0N1mcmSKLdBAanUUJoVkZIaJYay40zt8UAX73HJxHOZ5QCFkyXjp4fiLisL2YI-L1OeoHe0qKT0Ipl_yO8rM1Av7UBL-pwtNhmqfOaq0K3Lz6vy3eNbjSGNtso-aO67CiyxtwcbcJJ7gJ5VCP5nvkiuzrglEQHGuLODE05lk1LXojVgfZM9qxZmamJtPFMXs-HO3tD3ujF68ZZbqokJ3sCMVQ9xcVMg99sL4GMMWftjjKLfh4JtTehtWyKvVdYArHFhEKw1BFYZGnIveKTHETJwGVBDAOvGyRIQ_rPCPS-mciljWOJOJIWhxJ34F3BJ5lT8oRbl9Usy-yETkyVipU2g90pDWanXlquEIHOzbG47kwgQPPCHqSJBniK1fNhQycMOUEkxtIE_oPYcwdWOv0xEXMu80t6mQjAefyBHIOPF4200iK6it1dUR9fPIw0Kt14E6N9SVJdKCdhAJJFR0u6NDcbSknX21-dB_NYErz6MCrlmFO5vX3Rb33bzIewaWtg92-7G8Pdu7DZY7Grd2K42uwupgd6QdwIf--mMxnD61QYPD5rBnpF9ORoRw
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aA028cL8EBhgJBAiiJs7NQUJosFZMG13VAeqbcRIbKlXJaDvQ_hq_jnOcpCND8LYHHipVtR3luN-52ecC8CjkWRplKnK9MEzQQdHGzTKlXd8ECjHjC8_mV3zaS4ZDMZmkozX42ebCUFhlKxOtoC6qnM7Iezz10tqg7ZkmLGK0PXh9-M2lDlJ009q206ghsquPf6D7tni1s43_9WPOB_0Pb9-5TYcBN0dLeulmOi08k3IKdhRxmvm8MKnWvlJpbrI4M0UW6SA0OosSQrYyQkSx1lxopMUUAT73HJxPgiChthHJZOXs-YmIwzZJR8S9BeoKe2OKn4TKL_kdRWj7BfypFX5Ti6dDNk_d21p1OLj8P2_kFbjUGOFsq-aaq7Cmy2uw8b4JM7gO5UiPF_vkohzoglFwHGubOzE08lk1K_pjVgffMzrJZmauprPlMXs6Gu8fjPrjZy8ZVcCokM3sCsXQJigqZCp6YJ0eMMOvtmnKDfh4JtTehPWyKvVtYArXFhEKyVBFYZGnIveKTHETJwG1CjAOPG9RIg_r-iPS-m0iljWmJGJKWkxJ34E3BKTVTKodbn-o5l9kI4pkrFSotB_oSGs0R_PUcIWOd2yMx3NhAgeeEAwlSTjEWq6aRA18YaoVJreQJvQrwpg7sNmZiZuYd4dbBMpGMi7kCfwceLgappUU7Vfq6ojm-OR5oLfrwK0a9yuS6KI7CQWSKjoc0aG5O1JOv9q66T6ax1T-0YEXLfOcvNffN_XOv8l4ABvIP3JvZ7h7Fy5ytHntCR3fhPXl_Ejfgwv59-V0Mb9v5QODz2fNR78AV7Sp0A
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PeRsOnaliSed+care+Planning+for+oldER+people+with+frailty+%28PROSPER%29%3A+protocol+for+a+randomised+controlled+trial&rft.jtitle=Trials&rft.au=Heaven%2C+Anne&rft.au=Bower%2C+Peter&rft.au=Day%2C+Florence&rft.au=Farrin%2C+Amanda&rft.date=2024-01-02&rft.issn=1745-6215&rft.eissn=1745-6215&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs13063-023-07857-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13063_023_07857_1
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-6215&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-6215&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-6215&client=summon